Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127786161 | 12778616 | 1 | I | 20160915 | 20160926 | 20160926 | EXP | JP-MLMSERVICE-20160909-0419229-1 | JP-ACCORD-044288 | ACCORD | WATANABE Y, NIIZUMA H, SHIDO K, NIIHORI T, RIKIISHI T, SONODA Y ET AL. A NOVEL GENODERMATOSIS SYNDROME INDUCED BY SOMATIC BRAF V600E MOSAICISM, COMPRISING CONGENITAL ANAPLASTIC ASTROCYTOMA AND LINEAR SYRINGOCYSTADENOMA PAPILLIFERUM. NEURO-ONCOLOGY. 2016; 18(3). | 0.00 | I | Y | 0.00000 | 20160926 | OT | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127786161 | 12778616 | 1 | PS | ETOPOSIDE. | ETOPOSIDE | 1 | U | 74513 | |||||||||||
127786161 | 12778616 | 2 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | U | 0 | |||||||||||
127786161 | 12778616 | 3 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127786161 | 12778616 | 1 | Brain neoplasm |
127786161 | 12778616 | 2 | Brain neoplasm |
127786161 | 12778616 | 3 | Brain neoplasm |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127786161 | 12778616 | OT |
127786161 | 12778616 | LT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127786161 | 12778616 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |